NDATOPICALCREAM
Approved
Feb 1977
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
TOPICORT (desoximetasone) by PharmaIN is corticosteroid hormone receptor agonists [moa]. Approved for plaque psoriasis in patients 18 years of age, older (), older and 1 more indications. First approved in 1977.
Drug data last refreshed 18h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TOPICORT (desoximetasone) is a topical corticosteroid cream approved in 1977 for treating plaque psoriasis in adult patients. It works as a corticosteroid hormone receptor agonist, reducing inflammation and immune activity in affected skin. This established small-molecule product represents a mature therapeutic option in the dermatology market.
LOE Approaching
As LOE approaches, TOPICORT faces declining exclusivity and potential team consolidation; commercial roles should expect transition planning and focus on managed care defense.
Mechanism of Action
Corticosteroid Hormone Receptor Agonists
Indications (4)
Worked on TOPICORT at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.